Consolidation Therapy With Lenalidomide (Revlimid) With or Without Rituximab Followed by Maintenance Therapy With Revlimid After Autologous/Syngeneic Transplant for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 11 Jun 2015
At a glance
- Drugs Lenalidomide (Primary) ; Rituximab (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 04 Mar 2009 Actual initiation date (Feb 2009) added as reported by ClinicalTrials.gov.
- 04 Mar 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 06 Feb 2009 New trial record